BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14583471)

  • 21. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
    Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G
    Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
    Wang F; Reierstad S; Fishman DA
    Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell surface activation of progelatinase A (proMMP-2) and cell migration.
    Nagase H
    Cell Res; 1998 Sep; 8(3):179-86. PubMed ID: 9791731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors.
    Ueda J; Kajita M; Suenaga N; Fujii K; Seiki M
    Oncogene; 2003 Nov; 22(54):8716-22. PubMed ID: 14647466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.
    Nie J; Pei D
    Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
    Hernandez-Barrantes S; Shimura Y; Soloway PD; Sang QA; Fridman R
    Biochem Biophys Res Commun; 2001 Feb; 281(1):126-30. PubMed ID: 11178970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network.
    Kang T; Nagase H; Pei D
    Cancer Res; 2002 Feb; 62(3):675-81. PubMed ID: 11830519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
    Wang P; Nie J; Pei D
    J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A.
    Miyamori H; Takino T; Seiki M; Sato H
    Biochem Biophys Res Commun; 2000 Jan; 267(3):796-800. PubMed ID: 10673371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices.
    Ntayi C; Lorimier S; Berthier-Vergnes O; Hornebeck W; Bernard P
    Exp Cell Res; 2001 Oct; 270(1):110-8. PubMed ID: 11597133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
    Imai K; Yokohama Y; Nakanishi I; Ohuchi E; Fujii Y; Nakai N; Okada Y
    J Biol Chem; 1995 Mar; 270(12):6691-7. PubMed ID: 7896811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected with P. aeruginosa.
    Dong Z; Katar M; Alousi S; Berk RS
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3223-7. PubMed ID: 11726626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of membrane-type matrix metalloproteinase (MT-MMP) and activation of MMP-2 in lung cancer].
    Tokuraku M; Sato H; Watanabe Y; Seiki M
    Nihon Rinsho; 1995 Jul; 53(7):1822-6. PubMed ID: 7630026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts.
    Boyd RS; Balkwill FR
    Br J Cancer; 1999 May; 80(3-4):315-21. PubMed ID: 10408832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M; Thomas LE; Wheeler SE; Curry TE
    Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.
    Nomura H; Sato H; Seiki M; Mai M; Okada Y
    Cancer Res; 1995 Aug; 55(15):3263-6. PubMed ID: 7614460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
    Cao J; Rehemtulla A; Pavlaki M; Kozarekar P; Chiarelli C
    J Biol Chem; 2005 Mar; 280(12):10974-80. PubMed ID: 15637056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in Furin-Negative Colon Carcinoma LoVo Cells.
    Deryugina EI; Ratnikov BI; Yu Q; Baciu PC; Rozanov DV; Strongin AY
    Traffic; 2004 Aug; 5(8):627-41. PubMed ID: 15260832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.